Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Blood|June 26, 2009
Preclinical characterization of 1-7F9, a novel human anti-KIR receptor therapeutic antibody that augments natural killer-mediated killing of tumor cellsFrancois Romagné, Pascale André, Pieter Spee, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2007
Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46Thierry Walzer, Mathieu Bléry, Julie Chaix, et al.
The Journal of Clinical Investigation|September 17, 2003
Ex vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramersCheryl L Day, Nilufer P Seth, Michaela Lucas, et al.
Nature Biotechnology|January 12, 2023
Control of acute myeloid leukemia by a trifunctional NKp46-CD16a-NK cell engager targeting CD123Laurent Gauthier, Angela Virone-Oddos, Jochen Beninga, et al.
Cell|June 4, 2019
Multifunctional Natural Killer Cell Engagers Targeting NKp46 Trigger Protective Tumor ImmunityLaurent Gauthier, Ariane Morel, Nadia Anceriz, et al.
Cell Reports|May 23, 2019
Blocking Antibodies Targeting the CD39/CD73 Immunosuppressive Pathway Unleash Immune Responses in Combination Cancer TherapiesIvan Perrot, Henri-Alexandre Michaud, Marc Giraudon-Paoli, et al.
Open Research Europe|August 30, 2023
Targeting MICA/B with cytotoxic therapeutic antibodies leads to tumor controlMathieu Bléry, Manel Mrabet-Kraiem, Ariane Morel, et al.
Cell Reports. Medicine|February 19, 2026
Targeting BCMA in multiple myeloma with a trifunctional NK cell engagerAlexandre Tang, Laurent Gauthier, Elisa Zaghi, et al.
Cell|December 4, 2018
Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK CellsPascale André, Caroline Denis, Caroline Soulas, et al.
Science Immunology|November 15, 2024
A tetraspecific engager armed with a non-alpha IL-2 variant harnesses natural killer cells against B cell non-Hodgkin lymphomaOlivier Demaria, Guillaume Habif, Marie Vetizou, et al.
Pageof 7